Psychiatry and Neurology, Neurology · Carlsbad, CA
NPI
1346276375
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6010 Hidden Valley Rd Ste 200
Carlsbad, CA, 92011
Phone (760) 631-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
207,536 services
Medicare patients, 2024
425
Average age 70
Drug cost, 2024
$969K
2,306 prescriptions
Company payments, 2025
$126K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jack D Schim was code J0585 (injection, onabotulinumtoxina, 1 unit), 205,736 times for 283 patients. In total Jack D Schim billed 207,536 services in 32 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 205,736 | 283 | $4.92 | $1.0M |
| 64615 Musculoskeletal | Office | 609 | 210 | $123.63 | $75K |
| 95874 Musculoskeletal | Office | 232 | 74 | $68.91 | $16K |
| 64616 Musculoskeletal | Office | 138 | 41 | $111.78 | $15K |
| 99214 Office E&M - Established | Office | 85 | 67 | $96.88 | $8,235 |
| 64644 Musculoskeletal | Office | 83 | 26 | $151.94 | $13K |
| 64612 Musculoskeletal | Office | 64 | 21 | $156.82 | $10K |
| 99215 Office E&M - Established | Office | 64 | 51 | $146.37 | $9,368 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 62 | 53 | $13.04 | $809 |
| 99213 Office E&M - Established | Office | 58 | 49 | $69.12 | $4,009 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 56 | 17 | $0.54 | $30.2 |
| 64643 Musculoskeletal | Office | 35 | 12 | $77.91 | $2,727 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 29 | 20 | $25.48 | $739 |
| 64642 Musculoskeletal | Office | 25 | 11 | $121.85 | $3,046 |
| 64405 Musculoskeletal | Office | 24 | 14 | $54.28 | $1,303 |
By year: 2022 $986K for 171,902 services; 2023 $1.3M for 217,512 services; 2024 $1.2M for 207,536 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jack D Schim prescribed most often to Medicare patients was Sumatriptan Succinate, with 240 prescriptions and refills. In total Jack D Schim wrote 2,306 Medicare prescriptions that cost $969K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sumatriptan Succinate Generic | 240 | 293 | 57 | $4,759 |
| Naratriptan Hcl Generic | 124 | 145 | 30 | $3,567 |
| Botox Onabotulinumtoxina | 103 | 241 | 39 | $136K |
| Nurtec Odt Rimegepant Sulfate | 100 | 110 | 24 | $190K |
| Aimovig Autoinjector Erenumab-Aooe | 95 | 140 | 18 | $101K |
| Emgality Pen Galcanezumab-Gnlm | 84 | 123 | 17 | $84K |
| Rizatriptan Rizatriptan Benzoate | 83 | 88 | 23 | $1,417 |
| Topiramate Generic | 73 | 125 | 19 | $814 |
| Ubrelvy Ubrogepant | 72 | 77 | 20 | $105K |
| Gabapentin Generic | 63 | 115 | 17 | $2,319 |
| Ondansetron Odt Ondansetron | 57 | 57 | 16 | $543 |
| Amitriptyline Hcl Generic | 50 | 102 | 19 | $683 |
| Pregabalin Generic | 49 | 54 | Under 11 | $839 |
| Qulipta Atogepant | 48 | 48 | Under 11 | $50K |
| Alprazolam Generic | 46 | 47 | Under 11 | $52.95 |
Brand drugs: - claims; generic drugs: 1,606 claims; opioid claims: 82.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jack D Schim $126K ($126K in general payments such as food, travel and fees) from 15 companies. The largest payer was Ipsen Innovation with $44K.
| Company | Payments | Amount |
|---|---|---|
| Ipsen Innovation IPN.PA | 7 | $44K |
| Axsome Therapeutics, Inc. AXSM | 43 | $44K |
| Abbvie Inc. ABBV | 37 | $20K |
| Pfizer Inc. PFE | 9 | $8,830 |
| Lundbeck LLC | 11 | $8,518 |
| Tonix Medicines, Inc. | 3 | $63.53 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $41.35 |
| UCB, Inc. UCB.BR | 1 | $29.84 |
| Revance Therapeutics, Inc. | 1 | $26.34 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $22.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.